OK, so name a few of these companies.
If NWBO had released TLD in conjunction with a media blitz and a journal publication, with updated clinicaltrails.gov website, the share price would NOT have bombed. It would be over $4 right now as a company that has a product that can cure cancer and be the next Standard of Care for all solid-tumors.
I get that the journal article was not ready (presumably) but that does not mean you dribble the information KNOWING you will be attacked and can't respond. Knowing the shareprice is going to get destroyed. Especially after issuing a PR and sending out hints about big news coming in May/June.
All the BS about 'well the stock was at $0.70 and is back at $0.70, no loss, still beating the (fill-in-the-blank) for the year,' is just that. Do people not realize that investors bought millions of shares at $1.50+ and sold at $0.60-? Shorts ate up $millions at the expense of NWBO shareholders, increasing their supply of shares they can use to short the stock going forward.
So who is going to buy the stock up on the OTC, where we are still stuck and probably will be until approval? Not institutional investors. Not the investors you burned with the TLD headfake ('gosh, I sure would like to lose 50-70% of my investment'). Not the longs who are already fully invested. I am certainly not going to make the mistake of recommending NWBO to friends and family again.
Don't blame the shorts for something that was predictable. Something I predicted long ago. Something the company apparently predicted before NYAS. This was a management decision, one they will need to justify.
